Cocrystal Pharma Ownership
| COCP Stock | USD 2.07 0.03 1.43% |
Shares in Circulation | First Issued 2010-03-31 | Previous Quarter 10 M | Current Value 10 M | Avarage Shares Outstanding 11.6 M | Quarterly Volatility 16.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cocrystal |
Cocrystal Stock Ownership Analysis
About 32.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cocrystal Pharma has Price/Earnings (P/E) ratio of 193.33. The entity recorded a loss per share of 1.84. The firm last dividend was issued on the 24th of January 2018. Cocrystal Pharma had 1:12 split on the 11th of October 2022. Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious andor chronic viral diseases. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp Dohme Corp. to discover and develop proprietary influenza AB antiviral agents a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections and drug discovery collaboration with HitGen and InterX Inc. Cocrystal Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. For more info on Cocrystal Pharma please contact CPA CPA at 877 262 7123 or go to https://www.cocrystalpharma.com.Cocrystal Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cocrystal Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cocrystal Pharma backward and forwards among themselves. Cocrystal Pharma's institutional investor refers to the entity that pools money to purchase Cocrystal Pharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 428 | Clean Yield Group Inc | 2024-09-30 | 418 | Nvwm, Llc | 2024-09-30 | 84.0 | Royal Bank Of Canada | 2024-06-30 | 51.0 | Activest Wealth Management | 2024-06-30 | 1.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Fidelity Management And Research Company | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-06-30 | 0.0 | Vima Llc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 275.7 K | Renaissance Technologies Corp | 2024-09-30 | 130 K |
Cocrystal Pharma Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cocrystal Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cocrystal Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cocrystal Pharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cocrystal Pharma Outstanding Bonds
Cocrystal Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cocrystal Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cocrystal bonds can be classified according to their maturity, which is the date when Cocrystal Pharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Cocrystal Pharma Corporate Filings
10Q | 13th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 7th of May 2024 Other Reports | ViewVerify |
Pair Trading with Cocrystal Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Cocrystal Stock
| 0.57 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.55 | HLN | Haleon plc | PairCorr |
| 0.49 | BCH | Banco De Chile | PairCorr |
| 0.48 | SHG | Shinhan Financial | PairCorr |
| 0.44 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.